SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Current Assets | ₹275 Cr | ₹182 Cr | ₹140 Cr | ₹87 Cr | ₹92 Cr |
What is the latest Total Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹275 Cr |
Mar2023 | ₹182 Cr |
Mar2022 | ₹140 Cr |
Mar2017 | ₹87 Cr |
Mar2016 | ₹92 Cr |
How is Total Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹275 Cr | 51.24 | |
Mar2023 | ₹182 Cr | 29.96 | |
Mar2022 | ₹140 Cr | 61.55 | |
Mar2017 | ₹87 Cr | -5.59 | |
Mar2016 | ₹92 Cr | - |
Compare Total Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,014.4 Cr | -4.8% | 34.2% | 76.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -4.8% |
34.2% |
76.8% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses